TCL Archive In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors February 27, 1998
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009